![Joseph Petko](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Joseph Petko
Directeur de la Recherche - Actions chez Ashford Capital Management, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Theodore Ashford | M | 60 |
Ashford Capital Management, Inc.
![]() Ashford Capital Management, Inc. Investment ManagersFinance Ashford Capital Management, Inc. (Ashford) is an independent, SEC-registered investment advisor headquartered in Wilmington, Delaware. The firm was founded by Theodore H. Ashford in 1979. Ashford offers investment management services to institutions and high net worth individuals that seek to discover small growth companies. The firm offers both separately managed accounts and limited partnership investment opportunities. | - |
Joseph Pergolizzi | M | - |
Enalare Therapeutics, Inc.
![]() Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
Herm Cukier | M | 57 |
Enalare Therapeutics, Inc.
![]() Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
Gino Santini | M | 67 |
Enalare Therapeutics, Inc.
![]() Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
Mark Coleman | M | 56 |
Enalare Therapeutics, Inc.
![]() Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | 3 ans |
Bob Yedid | M | - |
Enalare Therapeutics, Inc.
![]() Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
Daniel Motto | M | - |
Enalare Therapeutics, Inc.
![]() Enalare Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Enalare Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops novel therapies for patients with life-threatening acute respiratory and critical care conditions, such as community drug overdose, post-operative respiratory depression, and apnea of prematurity. Enalare Therapeutics is based in Princeton, NJ. Enalare maintains rights to its novel compounds and intends to start additional clinical trials with ena-001 for several indications in the near term. The company was founded by Joseph V. Pergolizzi and is currently led by CEO Herm Cukier. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Gregory Xavier Falcon | M | - |
Ashford Capital Management, Inc.
![]() Ashford Capital Management, Inc. Investment ManagersFinance Ashford Capital Management, Inc. (Ashford) is an independent, SEC-registered investment advisor headquartered in Wilmington, Delaware. The firm was founded by Theodore H. Ashford in 1979. Ashford offers investment management services to institutions and high net worth individuals that seek to discover small growth companies. The firm offers both separately managed accounts and limited partnership investment opportunities. | 8 ans |
Matt P. Byrnes | M | - |
Ashford Capital Management, Inc.
![]() Ashford Capital Management, Inc. Investment ManagersFinance Ashford Capital Management, Inc. (Ashford) is an independent, SEC-registered investment advisor headquartered in Wilmington, Delaware. The firm was founded by Theodore H. Ashford in 1979. Ashford offers investment management services to institutions and high net worth individuals that seek to discover small growth companies. The firm offers both separately managed accounts and limited partnership investment opportunities. | 1 ans |
Emily A. Hickman | F | - |
Ashford Capital Management, Inc.
![]() Ashford Capital Management, Inc. Investment ManagersFinance Ashford Capital Management, Inc. (Ashford) is an independent, SEC-registered investment advisor headquartered in Wilmington, Delaware. The firm was founded by Theodore H. Ashford in 1979. Ashford offers investment management services to institutions and high net worth individuals that seek to discover small growth companies. The firm offers both separately managed accounts and limited partnership investment opportunities. | 8 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 10 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Joseph Petko
- Réseau Personnel